| NCT02654301 | Postprandial Hyperglycemia | Dietary Supplement: Test 1|Dietary Supplement: Test 2|Dietary Supplement: Test 3|Dietary Supplement: Control | Yonsei University | | 2014-06-01 | 2016-01-12 |
| NCT01957098 | Insulin Resistance | Dietary Supplement: Placebo comparator: 0% pentose|Dietary Supplement: Active comparator: 4% D-xylose|Dietary Supplement: Active comparator: 8% D-xylose|Dietary Supplement: Active comparator: 8% L-arabinose | University of Copenhagen|Danisco | | 2006-10-01 | 2013-10-07 |
| NCT02314455 | Eosinophilic Esophagitis | Other: D-xylose | Mayo Clinic | | 2014-09-01 | 2016-07-19 |
| NCT01324895 | Small Intestinal Bacterial Overgrowth Syndrome (SIBO)|Small Bowel Bacterial Overgrowth Syndrome (SBBOS) | | University of Florida | | 2010-08-01 | 2012-03-23 |
| NCT01762566 | Not-celiac Gluten (Wheat) Sensitivity | Dietary Supplement: wheat|Dietary Supplement: xylose | University of Palermo | | 2012-01-01 | 2014-09-14 |
| NCT01762579 | Not-celiac Wheat Sensitivity | Dietary Supplement: wheat flour|Dietary Supplement: Xylose | University of Palermo | Phase 3 | 2012-01-01 | 2016-12-30 |
| NCT03024775 | Non-celiac Wheat Sensitivity | Dietary Supplement: Wheat flour|Dietary Supplement: Placebo | University of Palermo | | 2017-01-01 | 2017-01-16 |
| NCT00015431 | Common Variable Immunodeficiency | | National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC) | | 2001-04-16 | 2017-01-24 |
| NCT00263237 | Common Variable Immunodeficiency | Drug: STA-5326 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC) | Phase 1 | 2005-12-02 | 2017-01-24 |
| NCT02199496 | CVID|Enteropathy|Chronic Diarrhea|Maldigestion|Malabsorption | Biological: Ustekinumab | National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC) | Phase 1|Phase 2 | 2014-07-16 | 2017-03-07 |
| NCT01760772 | Heart Disease | Drug: Exendin-9|Drug: GLP-1|Other: saline | David Dalessio|University of Cincinnati | | 2013-02-01 | 2013-01-02 |
| NCT00688974 | Obesity|Type 2 Diabetes | Procedure: Roux-en-Y gastric bypass|Procedure: Adjustable gastric band | University Hospital, Lille | Phase 2|Phase 3 | 2004-05-01 | 2016-08-17 |
